TGTX
Tg Therapeutics
$55.75
−$0.29 (−0.52%)Jul 27, 2026
Key metrics
The numbers that frame TGTX today
- Market cap
- $8.53B
- P/E (TTM)
- 18.5
- EV / FCF
- -623.1
- Gross margin
- 83.1%
- EV / Sales
- 12.6
- ROIC
- 13.5%
- Div yield
- 0%
- Debt / equity
- 1.3
- 52wk Low
- $25.28
- 52wk High
- $59.30
Growth
Revenue and earnings trend for TGTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TGTX
Is Tg Therapeutics a good buy?
Yes. Tg Therapeutics has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks mixed. The support signal is useful, but not decisive. We think Tg Therapeutics is selling at a high price, which cuts against the buy case.
What is the market capitalization of TGTX?
Tg Therapeutics's market capitalization is $8.53B.
What is the P/E ratio for TGTX stock?
Tg Therapeutics's current P/E ratio is 18.5.
What is the 52-week high for TGTX stock?
The 52-week high for Tg Therapeutics is $59.30. The current close of $55.75 is 6% below that high.
What is the 52-week low for TGTX stock?
The 52-week low for Tg Therapeutics is $25.28. The current close of $55.75 is 120.5% above that low.
Does TGTX stock pay dividends?
Tg Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TGTX?
Tg Therapeutics's Debt / Equity ratio is 1.29.